Paul Hadden
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Paul Hadden
Paul Hadden has spoken on 2 earnings calls across 1 company, most recently for Ligand Pharmaceuticals Inc on August 7, 2025.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Ligand Pharmaceuticals Inc (LGND)
Source not stated
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Ligand Pharmaceuticals Inc
Other people whose current roles at this company are on record from its filings.
- Todd C. Davis CEO, Board Member
- Tavo Espinoza CFO
- Matthew Korenberg COO
- Jason Haas Board Member
- Jason M. Aryeh Board Member
- Jennifer Cochran, Ph.D. Board Member
- John L. LaMattina Board Member
- John L. LaMattina, Ph.D. Board Member
- John W. Kozarich Board Member
- John W. Kozarich, Ph.D. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.